End stage kidney disease (ESKD) is a major global health issue that necessitates renal replacement therapy (RRT) for patient survival. In 2010, approximately 2.6 million people worldwide received RRT [1]. This figure is projected to more than double to 5.4 million by 2030, with the most rapid growth...
Malnutrition is widely recognized as a prevalent issue among patients undergoing maintenance hemodialysis (MHD) and is influenced by numerous factors. Among these, abnormal protein metabolism, specifically the dysfunctional synthesis and degradation of muscle protein, is pivotal in the development of...
End-stage renal disease (ESRD) is a growing global health concern, with arteriovenous fistulas (AVFs) and grafts (AVGs) being the primary vascular access choices for hemodialysis due to their durability and lower infection rates [1, 2]. However, AVF creation introduces significant hemodynamic alterations,...
Kidney failure is considered one of the leading cause of morbidity and mortality worldwide. Hemodialysis (HD) is the most common modality of renal replacement therapy for end-stage kidney disease (ESKD) patients, and its rate of uptake has been increasing in China [1]. However, the health-related quality...
Achieving adequate peritoneal ultrafiltration (UF) and sodium removal is a challenge in peritoneal dialysis (PD). Despite volume management being an important component of PD prescription [1, 2], volume overload remains a common problem for PD patients with a prevalence ranging from 56 to 72% [3, 4–5]....